#1 Clinical Trials Search in Europe

Somatostatin

Somatostatin, a naturally occurring hormone in the body, has been the subject of numerous clinical trials exploring its potential therapeutic applications. These trials investigate the use of somatostatin in various medical conditions, including pancreatic fistula prevention, gastric cancer complications, liver failure treatment, and neuroendocrine tumor management. Researchers are studying how somatostatin affects glucose metabolism, hormone regulation, and other bodily functions to determine its efficacy in different clinical scenarios.

Table of Contents

What is Somatostatin?

Somatostatin is a naturally occurring hormone in the human body that plays various important roles. As a medication, it’s also known by other names such as Stilamin, Sandostatin, or octreotide[2][6]. This hormone helps regulate many bodily functions by inhibiting the release of other hormones and affecting how our body processes certain substances.

In medical settings, somatostatin is used as a drug to treat various conditions. It works by mimicking the effects of the natural hormone in our body, helping to control certain processes that may be overactive in some diseases[1].

Medical Uses of Somatostatin

Somatostatin is used to treat a variety of medical conditions. Here are some of its primary uses:

  • Pancreatic Fistula Prevention: It’s used after pancreatic surgery to prevent a condition called pancreatic fistula, which is an abnormal connection that forms between the pancreas and other organs[1][2].
  • Gastrointestinal Bleeding: Somatostatin can help control bleeding in the upper gastrointestinal tract[3].
  • Neuroendocrine Tumors: It’s used in the treatment of certain types of tumors that affect hormone-producing cells, particularly in the digestive system and pancreas[6].
  • Acromegaly and Growth Hormone Disorders: Somatostatin can help manage conditions related to excessive growth hormone production[5].
  • Diabetes Research: It’s being studied for its effects on glucose metabolism, which could have implications for diabetes treatment[7].

How Somatostatin is Administered

Somatostatin is typically administered in the following ways:

  • Intravenous Infusion: Often given as a continuous infusion through a vein, especially after surgery or for acute conditions[1].
  • Subcutaneous Injection: Some forms of somatostatin analogues (similar drugs) can be given as injections under the skin[1].
  • Long-Acting Injections: For chronic conditions, long-acting forms of somatostatin analogues may be given as monthly injections[6].

The dosage and duration of treatment can vary greatly depending on the specific condition being treated and the individual patient’s needs.

Potential Side Effects

While somatostatin is generally well-tolerated, it can cause some side effects. These may include:

  • Nausea or stomach discomfort
  • Changes in blood sugar levels
  • Diarrhea or constipation
  • Headache
  • Dizziness

It’s important to discuss potential side effects with your healthcare provider before starting treatment[6].

Ongoing Research and Future Potential

Researchers are continually exploring new potential uses for somatostatin. Some areas of ongoing research include:

  • Liver Failure Treatment: Studies are investigating whether somatostatin can help in the treatment of liver failure after partial liver removal surgery[4].
  • Prostate Cancer: Some research is looking into the potential of somatostatin in treating certain types of advanced prostate cancer[8].
  • Brain Glucose Metabolism: Scientists are studying how somatostatin affects glucose metabolism in the brain, which could have implications for understanding and treating conditions like diabetes and hypoglycemia unawareness[7][9].

These ongoing studies highlight the potential for somatostatin to play an even larger role in medical treatment in the future. However, it’s important to remember that research is ongoing, and these potential uses are still being evaluated for safety and effectiveness.

Aspect Details
Main Conditions Studied Pancreatic fistula, Gastric cancer complications, Liver failure, Neuroendocrine tumors, Glucose metabolism, Prostate cancer
Administration Methods Continuous intravenous infusion, Long-acting injections
Dosages Used Varies by study: e.g., 250μg/h for 120 hours, 30mg monthly injections
Primary Outcomes Measured Pancreatic fistula incidence, Progression-free survival, Proinsulin clearance, Brain glycogen turnover rate
Secondary Outcomes Complication rates, Quality of life, Cost-effectiveness, Overall survival
Study Designs Randomized controlled trials, Open-label studies, Comparative studies
Patient Populations Post-surgery patients, Cancer patients, Diabetes patients, Healthy volunteers

FAQ

  • What is somatostatin and how is it used in clinical trials? Somatostatin is a hormone naturally produced in the body that inhibits the release of several other hormones. In clinical trials, it is often used as a medication to treat various conditions. It is typically administered through intravenous infusion or as long-acting injections to study its effects on different medical issues such as pancreatic fistula prevention, gastric cancer complications, and neuroendocrine tumors.
  • What are some of the main conditions being studied with somatostatin? Clinical trials are investigating somatostatin's potential in several conditions, including post-operative pancreatic fistula prevention, complications after gastric cancer surgery, post-hepatectomy liver failure, neuroendocrine tumors, and its effects on glucose metabolism. Some studies are also looking at its use in prostate cancer and diabetes management.
  • How is somatostatin administered in these clinical trials? In most of the clinical trials, somatostatin is administered either through continuous intravenous infusion or as long-acting injections. For example, in some studies, it is given as an intravenous infusion at a rate of 250μg/h for 120 hours, while in others, it's administered as monthly injections of long-acting formulations like Sandostatin LAR 30mg.
  • What are some potential benefits of somatostatin being studied? Researchers are investigating several potential benefits of somatostatin, including its ability to prevent post-operative pancreatic fistulas, reduce complications after gastric cancer surgery, improve liver function after hepatectomy, manage neuroendocrine tumors, and regulate glucose metabolism. Some studies also suggest it may have a role in prostate cancer treatment and diabetes management.
  • Are there any side effects or risks associated with somatostatin use in these trials? While the clinical trials are designed to assess both the efficacy and safety of somatostatin, potential side effects can include gastrointestinal symptoms, changes in blood sugar levels, and gallbladder issues. The specific risks and side effects can vary depending on the dosage, duration of treatment, and the condition being treated. Each trial carefully monitors participants for any adverse events to ensure patient safety.

Ongoing Clinical Trials on Somatostatin

  • Study on the Effectiveness of Somatostatin Eye Drops for Patients with Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Somatostatin: A hormone that inhibits the release of several other hormones in the body. It is used as a medication in various clinical trials to treat different medical conditions.
  • Pancreatic fistula: An abnormal connection that forms between the pancreas and other organs, often as a complication after pancreatic surgery. It can lead to leakage of pancreatic fluids.
  • Neuroendocrine tumor: A type of tumor that develops from cells of the endocrine (hormone-producing) and nervous systems. These tumors can occur in various parts of the body.
  • Gastroenteropancreatic neuroendocrine tumor: A specific type of neuroendocrine tumor that occurs in the digestive system, including the stomach, intestines, and pancreas.
  • Post-hepatectomy liver failure: A serious complication that can occur after the surgical removal of part of the liver (hepatectomy), characterized by impaired liver function.
  • Castrate-resistant prostate cancer: A form of prostate cancer that continues to progress despite treatments that lower testosterone levels.
  • Hypoglycemia: A condition characterized by abnormally low blood sugar levels, which can cause various symptoms and potentially be dangerous if severe.
  • Proinsulin: A precursor molecule to insulin, produced by the pancreas, which is converted to insulin before being released into the bloodstream.
  • Peptide receptor radionuclide therapy (PRRT): A targeted treatment for certain types of neuroendocrine tumors that uses radioactive substances attached to molecules that bind to tumor cells.
  • Pancreaticoduodenectomy: A complex surgical procedure that removes the head of the pancreas, the first part of the small intestine, the gallbladder, and the bile duct. Also known as the Whipple procedure.

References

  1. https://clinicaltrials.gov/study/NCT03000946
  2. https://clinicaltrials.gov/study/NCT03349424
  3. https://clinicaltrials.gov/study/NCT01914692
  4. https://clinicaltrials.gov/study/NCT02882347
  5. https://clinicaltrials.gov/study/NCT01062529
  6. https://clinicaltrials.eu/trial/study-on-continuing-somatostatin-analogues-with-sunitinib-octreotide-and-lutetium-177lu-oxodotreotide-for-patients-with-neuroendocrine-tumors/
  7. https://clinicaltrials.gov/study/NCT00786825
  8. https://clinicaltrials.gov/study/NCT02631616
  9. https://clinicaltrials.gov/study/NCT00793741